[1]
Sankey, MD, CCFP (EM), C., Setnik, PhD, B., Harsanyi, BSc (Hon), MLS, MBA, PStat. (SSC), PSTAT® (ASA), Z., Michalko, PharmD, MBA, K., Yang, PhD, Z. and Geoffroy, MDCM, MSc, FCFP, DABAM, P. 2016. Opioid use following the introduction of an extended-release oxycodone formulation with tamper-resistant properties: Prospective historical chart review in methadone-maintained patients. Journal of Opioid Management. 12, 2 (Mar. 2016), 149–159. DOI:https://doi.org/10.5055/jom.2016.0327.